Obesity Paradox and 12 Month Outcome in Patients with Atrial Fibrillation

被引:8
|
作者
Rodriguez-Reyes, Humberto [1 ]
Lara-Vaca, Susano [2 ]
Ochoa-Guzman, Ana [3 ]
Chiquete, Erwin [4 ]
机构
[1] Hosp Cardiol Aguascalientes, Dept Cardiol, Aguascalientes, Aguascalientes, Mexico
[2] Unidad Med Alta Especialidad T1 IMSS, Dept Cardiol, Guanajuato, Mexico
[3] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Unidad Biol Mol, Mexico City, DF, Mexico
[4] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Neurol & Psiquiatria, Mexico City, DF, Mexico
[5] Registro Mexicano Fibrilac Auricular, Mexico City, DF, Mexico
关键词
Arrhythmias; Antiarrhythmic; Atrial fibrillation; Mexico; Obesity paradox; Outcome; Registry; RHYTHM-CONTROL;
D O I
10.1016/j.arcmed.2020.10.015
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background and aim. Obesity increases the risk of atrial fibrillation (AF) while it may impact the outcome of patients with AF. The clinical implications of this relationship are not completely clear. We aimed to analyze the association of traditional anthropometric measures of excessive adiposity with 12 month case fatality rate (CFR) in patients with AF. Methods. This was a multicenter, longitudinal, observational study on adults with documented AF, excluding records of AF secondary to reversible causes. Anthropometric variables were registered at baseline, and a central committee validated the 12 month outcomes. Results. We studied 1193 patients (median age: 69.14 years, 55.2% women). At baseline, rhythm control was established for 476 (39.9%) subjects, while frequency control was offered to 717 (60.1%) participants. The 12 month all-cause CFR was 8.9%. A high basal body mass index (BMI), waist-to-height ratio (WHtR) and waist circumference (WC) were associated with lower CFR in bivariate analyses. In a Cox-proportional hazards model, variables associated with 12 month all-cause CFR were BMI categories (HR: 0.736, 95% CI: 0.584-0.928), chronic heart failure (HR: 1.738, 95% CI: 1.127-2.680), chronic kidney disease (HR: 2.269, 95% CI: 1.162-4.429) and carotid stenosis > 50% (HR: 5.342, 95% CI: 1.661-17.181). Conclusion. The risk of death at one year in patients with AF is inversely associated with a high BMI and directly associated with the presence of chronic kidney disease, carotid stenosis, and chronic heart failure in this cohort of patients with AF. The causes and implications of this apparent obesity paradox should be addressed in the future. (C) 2021 IMSS. Published by Elsevier Inc.
引用
收藏
页码:233 / 239
页数:7
相关论文
共 50 条
  • [31] Catheter ablation for atrial fibrillation in patients with obesity
    Cha, Yong-Mei
    Friedman, Paul A.
    Asirvatham, Samuel J.
    Shen, Win-Kuang
    Munger, Thomas M.
    Rea, Robert F.
    Brady, Peter A.
    Jahangir, Arshad
    Monahan, Kristi H.
    Hodge, David O.
    Meverden, Ryan A.
    Gersh, Bernard J.
    Hammill, Stephen C.
    Packer, Douglas L.
    CIRCULATION, 2008, 117 (20) : 2583 - 2590
  • [32] Catheter ablation for atrial fibrillation in patients with obesity
    Estes, N. A. Mark, III
    HEART RHYTHM, 2008, 5 (08) : 1227 - 1227
  • [33] Obesity Paradox in Atrial Fibrillation: Implications for Outcomes and Relationship with Oral Anticoagulant Drugs
    Marco Proietti
    Giuseppe Boriani
    American Journal of Cardiovascular Drugs, 2020, 20 : 125 - 137
  • [34] Obesity Paradox in Atrial Fibrillation: Implications for Outcomes and Relationship with Oral Anticoagulant Drugs
    Proietti, Marco
    Boriani, Giuseppe
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020, 20 (02) : 125 - 137
  • [35] Atrial fibrillation progression and outcome in patients with young-onset atrial fibrillation
    De With, Ruben R.
    Marcos, Ernaldo G.
    Van Gelder, Isabelle C.
    Rienstra, Michiel
    EUROPACE, 2018, 20 (11): : 1750 - 1757
  • [36] Is Obesity Associated With the Predicted 6-Month Mortality in Patients With Atrial Fibrillation and Acute Coronary Syndrome?
    Chesler, Roseann
    Fung, Daniel
    Kamran, Haroon
    Cavusoglu, Erdal
    Mitchell, Judith E.
    CIRCULATION, 2018, 137
  • [37] The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial
    Sandhu, Roopinder K.
    Ezekowitz, Justin
    Andersson, Ulrika
    Alexander, John H.
    Granger, Christopher B.
    Halvorsen, Sigrun
    Hanna, Michael
    Hijazi, Ziad
    Jansky, Petr
    Lopes, Renato D.
    Wallentin, Lars
    EUROPEAN HEART JOURNAL, 2016, 37 (38) : 2869 - 2878
  • [38] Balloon technologies for pulmonary vein isolation-12-month outcome and comparison of the novel radiofrequency balloon with the cryoballoon in patients with paroxysmal atrial fibrillation
    van den Bruck, Jan-Hendrik
    Woermann, Jonas
    Sultan, Arian
    Filipovic, Karlo
    Seuthe, Katharina
    Erlhoefer, Susanne
    Scheurlen, Cornelia
    Dittrich, Sebastian
    Schipper, Jan-Hendrik
    Lueker, Jakob
    Steven, Daniel
    CLINICAL RESEARCH IN CARDIOLOGY, 2024, 114 (1) : 93 - 102
  • [39] Physical activity and outcome in patients with atrial fibrillation
    Brenner, R.
    Aeschbacher, S.
    Blum, S.
    Meyre, P.
    Ammann, P.
    Erne, P.
    Moschovitis, G.
    Di Valentino, M.
    Shah, D.
    Schlaepfer, J.
    Kuehne, M.
    Sticherling, C.
    Osswald, S.
    Conen, D.
    EUROPEAN HEART JOURNAL, 2018, 39 : 197 - 198
  • [40] Functional outcome in stroke patients with atrial fibrillation
    Karatas, M
    Dilek, A
    Erkan, H
    Yavuz, N
    Sözay, S
    Akman, N
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2000, 81 (08): : 1025 - 1029